E-Mail
According to data from a cohort of adult and pediatric patients with antibody deficiencies, patients that often fail to make protective immune responses to infections and vaccinations showed robust T-cell activity and humoral immunity against SARS-CoV-2 structural proteins. The new study, led by researchers at Children s National Hospital, is the first to demonstrate a robust T-cell response against SARS-CoV-2 in immunocompromised patients. If T-cell responses to SARS-CoV-2 are indeed protective, then it could suggest that adoptive T-cell immunotherapy might benefit more profoundly immunocompromised patients, said Michael Keller, M.D., director of the Translational Research Laboratory in the Program for Cell Enhancement and Technologies for Immunotherapy (CETI) at Children s National. Through our developing phase I T-cell immunotherapy protocol, we intend to investigate if coronavirus-specific T-cells may be protective following bone marrow transplantation, as well as
Key Discoveries in Cancer Treatment to Be Presented During the Virtual 2020 AACC Annual Scientific Meeting
hometownregister.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hometownregister.com Daily Mail and Mail on Sunday newspapers.
Advances in COVID-19 Testing, Artificial Intelligence, Cancer Therapies, and The Future of Precision Medicine to Be Explored at The All-Virtual 2020 AACC Annual Scientific Meeting
idahostatejournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from idahostatejournal.com Daily Mail and Mail on Sunday newspapers.
Search jobs 13-Dec-2020 Key Discoveries in Cancer Treatment to Be Presented During the Virtual 2020 AACC Annual Scientific Meeting
CHICAGO, Dec. 13, 2020 /PRNewswire/ During the all-virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo, leading scientific experts will dive into the groundbreaking advances that are the future of cancer care. One plenary session will focus on the cutting-edge treatment known as T cell therapy, while another will showcase recent discoveries about tumor metabolism that could lead to new, more effective cancer drugs.
Expanding the Reach of T Cell Therapy
T cell therapies train the immune system to target and destroy tumor cells, and have emerged in recent years as a promising alternative to chemotherapy and radiation. Immunotherapy has fewer side effects and has the potential to greatly increase patient survival rates, as T cells can live in the blood for years after a patient s initial tre